[1] |
BROADLEY L, CLARK K, RITCHIE G. Prevention and management of hyperglycaemic crisis[J]. Nurs Stand,2019,34(7):75-82. DOI:10.7748/ns.2019.e11387.
|
[2] |
KIM S. Burden of hospitalizations primarily due to uncontrolled diabetes:implications of inadequate primary health care in the United States[J]. Diabetes Care,2007,30(5):1281-1282. DOI:10.2337/dc06-2070.
|
[3] |
武仁华,袁丽,唐莉.持续皮下注射胰岛素治疗糖尿病高血糖危象效果观察[J]. 护理学杂志,2007,22(1):25-26.
|
[4] |
李晓燕,孟凡杰,段玉龙,等. 改良早期预警评分、血糖值评分及两评分结合预测糖尿病急性并发症患者预后能力的对比研究[J]. 实用医学杂志,2018,34(3):397-400.
|
[5] |
SAVAGE M W, DHATARIYA K K, KILVERT A,et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis[J]. Diabet Med,2011,28(5):508-515. DOI:10.1111/j.1464-5491.2011.03246.x.
|
[6] |
CORWELL B, KNIGHT B, OLIVIERI L,et al. Current diagnosis and treatment of hyperglycemic emergencies[J]. Emerg Med Clin North Am,2014,32(2):437-452. DOI:10.1016/j.emc.2014.01.004.
|
[7] |
万静波,叶赟,杨旻星,等. 高血糖危象患者在停止静脉输注胰岛素向皮下注射胰岛素时转换方式的探讨[J]. 中国糖尿病杂志,2018,26(2):104-106.
|
[8] |
POZZILLI P, BATTELINO T, DANNE T,et al. Continuous subcutaneous insulin infusion in diabetes:patient populations,safety,efficacy,and pharmacoeconomics[J]. Diabetes Metab Res Rev,2016,32(1):21-39. DOI:10.1002/dmrr.2653.
|
[9] |
杨靖,赵志波,吴丽,等. 胰岛素强化治疗对新发2型糖尿病非肥胖患者血浆促泌素的影响[J]. 实用医学杂志,2019,35(8):1288-1291.
|
[10] |
林秀红,熊稀霖,徐明彤,等. 新诊断型糖尿病患者血脂比值特点及短期胰岛素强化治疗对其影响[J]. 实用医学杂志,2017,33(11):1781-1785.
|
[11] |
栾晓军,陈劲松,陈小雨,等. 胰岛素泵联合速效胰岛素类似物治疗糖尿病酮症酸中毒疗效观察[J]. 内科急危重症杂志,2005,11(4):161-163.
|
[12] |
KITABCHI A E, UMPIERREZ G E, MILES J M,et al. Hyperglycemic crises in adult patients with diabetes[J]. Diabetes Care,2009,32(7):1335-1343. DOI:10.2337/dc09-9032.
|
[13] |
NYENWE E A, KITABCHI A E. Evidence-based management of hyperglycemic emergencies in diabetes mellitus[J]. Diabetes Res Clin Pract,2011,94(3):340-351. DOI:10.1016/j.diabres.2011.09.012.
|
[14] |
FISHER J N, SHAHSHAHANI M N, KITABCHI A E. Diabetic ketoacidosis:low-dose insulin therapy by various routes[J]. N Engl J Med,1977,297(5):238-241. DOI:10.1056/NEJM197708042970502.
|
[15] |
ANDRADE-CASTELLANOS C A, COLUNGA-LOZANO L E, DELGADO-FIGUEROA N,et al. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis[J]. Cochrane Database Syst Rev,2016 (1):CD011281. DOI:10.1002/14651858.CD011281.pub2.
|
[16] |
DELLA MANNA T, STEINMETZ L, CAMPOS P R,et al. Subcutaneous use of a fast-acting insulin analog:an alternative treatment for pediatric patients with diabetic ketoacidosis[J]. Diabetes Care,2005,28(8):1856-1861. DOI:10.2337/diacare.28.8.1856.
|
[17] |
ERSÖZ H O, UKINC K, KÖSE M,et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients[J]. Int J ClinPract,2006,60(4):429-433. DOI:10.1111/j.1368-5031.2006.00786.x.
|
[18] |
KAROLI R, FATIMA J, SALMAN T,et al. Managing diabetic ketoacidosis in non-intensive care unit setting:Role of insulin analogs[J]. Indian J Pharmacol,2011,43(4):398-401. DOI:10.4103/0253-7613.83109.
|
[19] |
UMPIERREZ G E, LATIF K, STOEVER J,et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis[J]. Am J Med,2004,117(5):291-296. DOI:10.1016/j.amjmed.2004.05.010.
|
[20] |
UMPIERREZ G E, CUERVO R, KARABELL A,et al. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart[J]. Diabetes Care,2004,27(8):1873-1878. DOI:10.1007/s12020-018-1635-z.
|
[21] |
SCHUMANN C, FAUST M. Diabetic ketoacidosis and hyperosmolar hyperglycemic state[J]. Dtsch Med Wochenschr,2018,143(6):384-391. DOI:10.1055/s-0043-114493.
|
[22] |
ROACH P. New insulin analogues and routes of delivery:pharmacodynamic and clinical considerations[J]. Clin Pharmacokinet,2008,47(9):595-610. DOI:10.2165/00003088-200847090-00003.
|
[23] |
PETERS A L, AHMANN A J, BATTELINO T,et al. Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2016,101(11):3922-3937. DOI:10.1210/jc.2016-2534.
|
[24] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志,2018,38(4):292-344. DOI:10.19538/j.nk2018040108.
|